MHRA Issues February 2026 Safety Roundup for Medicines and Medical Devices
The MHRA has released its February 2026 safety roundup, providing critical updates and advice for users of various medicines and medical devices.
What Happened
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued its monthly safety roundup for February 2026. This alert serves as a compilation of the latest safety advice and regulatory actions concerning medicines and medical devices to ensure patient and user safety.
Which Products Are Affected
The roundup covers a range of medicines and medical devices. While specific product names, batch numbers, or model identifiers were not detailed in the summary alert, the notice applies to various products regulated under the MHRA’s safety oversight as of February 2026.
What You Should Do
Consumers and healthcare professionals are advised to review the full safety roundup on the official government website. If you use medicines or medical devices, check the specific listings in the roundup to see if your products are included. For further information or to report issues, users can contact the MHRA directly through their official channels.
Why This Matters
This roundup is essential for maintaining public health standards by communicating potential risks and necessary precautions for medical products currently in use.
Source
Source: MHRA Official Notice
Related Articles
Rayner Pharmaceuticals Limited Issues Defect Notification for Dropodex 0.1% Eye Drops
MHRA · February 25, 2026
Syri Limited Recalls Baclofen 10mg/5ml Oral Solution Due to Crystallisation Concerns
MHRA · February 16, 2026
Aspar Pharmaceuticals Ltd Recalls Ibuprofen and Ibucalm 200mg Tablets Due to Packaging Defect
MHRA · February 16, 2026